226330.Kq
The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through software development and related services.
Business. The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through software development and related services.
At a glance
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through software development and related services.
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 16,345,598,350, which is significantly higher than its total liabilities of KRW 14,755,693,290. The liquidity FPT score indicates a low risk of liquidity distress, supported by a current ratio of 1.42. The price-to-book ratio of 1.85 suggests that the market values the company at a premium to its book value, indicating investor confidence in its intangible assets and future earnings potential.
Profitability metrics reveal a challenging financial position, with a net loss of KRW 17,378,023,890 and an operating loss of KRW 15,264,745,170. The return on equity of -0.5468 and return on assets of -0.3734 indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. These figures are below the industry median for profitability, suggesting that the company is underperforming relative to its peers in the software industry.
The company's revenue is concentrated in the health care technology segment, with no disclosed geographic breakdown. This concentration may expose the company to sector-specific risks, such as regulatory changes or shifts in demand for health care software solutions. The absence of detailed geographic exposure data limits the ability to assess regional risk factors comprehensively.
The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. Historical revenue data shows a revenue of KRW 3,429,231,740, but the operating and net losses suggest that the company is not currently expanding profitably. The lack of positive growth indicators may deter investors seeking long-term appreciation.
Risk factors include a low liquidity risk and a low dilution risk, as no immediate filing-based liquidity or dilution flags were detected. The dilution potential is also low, with no significant adjustments applied to the valuation metrics. However, the company's negative operating and net income may raise concerns about its long-term sustainability and ability to meet financial obligations.
Recent events, including filings and transcripts, have not been disclosed in the provided data. Therefore, there is no information available to assess the company's recent strategic moves or market reactions to its performance.
- The company has a strong liquidity position with cash and equivalents exceeding total liabilities.
- The company is currently unprofitable, with significant net and operating losses.
- The company's revenue is concentrated in the health care technology segment, with no geographic diversification disclosed.
- The company's growth trajectory is uncertain, with no positive financial indicators for the current or next fiscal year.
- The company presents low liquidity and dilution risks, but its negative profitability metrics may affect long-term sustainability.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Forward curve
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 226330.KQ Market data — financials · 2026-05-26